Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine-Reference-Cited by-同舟云学术

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

Published:2020-04-24 Issue:6 Volume:79 Page:837-839
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Mathian Alexis^ORCID,Mahevas Matthieu,Rohmer Julien,Roumier Mathilde,Cohen-Aubart Fleur,Amador-Borrero Blanca,Barrelet Audrey,Chauvet Cecile,Chazal Thibaud,Delahousse Michel,Devaux Mathilde,Euvrard Romain,Fadlallah Jehane,Florens Nans,Haroche Julien,Hié Miguel,Juillard Laurent,Lhote Raphael,Maillet Thibault,Richard-Colmant Gaelle,Palluy Jean Baptiste,Pha Micheline,Perard Laurent,Remy Philippe,Rivière Etienne,Sène Damien,Sève Pascal,Morélot-Panzini Capucine,Viallard Jean-François,Virot Jean-Simon,Benameur Neila,Zahr Noël,Yssel Hans,Godeau Bertrand,Amoura Zahir

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference10 articles.

1. Savarino A , Boelaert JR , Cassone A , et al . Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis 200:722–7.

2. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;Gautret;Int J Antimicrob Agents,2020

3. To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic

4. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus;Hochberg;Arthritis Rheum,1997

5. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the COVID-19 on Patients with Systemic Lupus Erythematosus during the First Pandemic Wave in China;2024-03-18

2. Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus;JCI Insight;2024-03-08

3. Bioinformatics and systems-biology approach to identify common pathogenic mechanisms for COVID-19 and systemic lupus erythematosus;Autoimmunity;2024-02-08

4. Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis;Lupus;2024-01-09

5. COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study;Immunologic Research;2023-12-22